Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia

Schizophrenia Research

Volumn 131, Issue 1-3, 2011, Pages 174-183

  Smith, Matthew J ^a   Wang, Lei ^a   Cronenwett, Will ^a   Goldman, Morris B ^a   Mamah, Daniel ^b   Barch, Deanna M ^b,c   Csernansky, John G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alcohol; Neuroimaging; Schizophrenia; Shape analysis

Indexed keywords

ALCOHOLISM; ANALYSIS OF VARIANCE; ARTICLE; BRAIN MALFORMATION; BRAIN MAPPING; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; MALE; MENTAL PATIENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBCORTEX; THALAMUS;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BRAIN MAPPING; COGNITION DISORDERS; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; THALAMUS;

EID: 80051786475     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.05.014     Document Type: Article

References (48)

1. Andreasen N.C. The Scale for the Assessment of Negative Symptoms 1983, The University of Iowa, Iowa City, IA.
2. Andreasen N.C. The Scale for the Assessment of Positive Symptoms 1983, The University of Iowa, Iowa City, IA.
3. Brahmbhatt S.B., Haut K., Csernansky J.G., Barch D.M. Neural correlates of verbal and nonverbal working memory deficits in individuals with schizophrenia and their high-risk siblings. Schizophr. Res. 2006, 87(1-3):191-204.
4. Brandt G.N., Bonelli R.M. Structural neuroimaging of the basal ganglia in schizophrenic patients: a review. Wien. Med. Wochenschr. 2008, 158(3-4):84-90.
5. Buckner R.L., Head D., Parker J., Fotenos A.F., Marcus D., Morris J.C., et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. NeuroImage 2004, 23(2):724-738.
6. Byne W., Hazlett E.A., Buchsbaum M.S., Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathol 2009, 117(4):347-368.
7. Chambers R.A., Krystal J.H., Self D.W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 2001, 50(2):71-83.
8. Corson P.W., Nopoulos P., Miller D.D., Arndt S., Andreasen N.C. Change in basal ganglia volume over 2years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 1999, 156(8):1200-1204.
9. Csernansky J.G., Schindler M.K., Splinter N.R., Wang L., Gado M., Selemon L.D., et al. Abnormalities of thalamic volume and shape in schizophrenia. Am J Psychiatry 2004, 161(5):896-902.
10. Csernansky J.G., Wang L., Jones D., Rastogi-Cruz D., Posener J.A., Heydebrand G., et al. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am J Psychiatry 2002, 159(12):2000-2006.
11. Csernansky J.G., Wang L., Joshi S.C., Ratnanather J.T., Miller M.I. Computational anatomy and neuropsychiatric disease: probabilistic assessment of variation and statistical inference of group difference, hemispheric asymmetry, and time-dependent change. NeuroImage 2004, 23(Suppl 1):S56-S68.
12. Deshmukh A., Rosenbloom M.J., De Rosa E., Sullivan E.V., Pfefferbaum A. Regional striatal volume abnormalities in schizophrenia: effects of comorbidity for alcoholism, recency of alcoholic drinking, and antipsychotic medication type. Schizophr. Res. 2005, 79(2-3):189-200.
13. Drake R.E., Osher F.C., Wallach M.A. Alcohol use and abuse in schizophrenia. A prospective community study. J. Nerv. Ment. Dis. 1989, 177(7):408-414.
14. Fadda F., Rossetti Z.L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog. Neurobiol. 1998, 56(4):385-431.
15. Fein G., Di Sclafani V., Cardenas V.A., Goldmann H., Tolou-Shams M., Meyerhoff D.J. Cortical gray matter loss in treatment-naive alcohol dependent individuals. Alcohol. Clin. Exp. Res. 2002, 26(4):558-564.
16. First M.B., Spitzer R.L., Miriam G., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition 2002, Biometrics Research, New York State Psychiatric Institute, New York, NY.
17. Green A.I., Salomon M.S., Brenner M.J., Rawlins K. Treatment of schizophrenia and comorbid substance use disorder. Curr Drug Targets CNS Neurol Disord 2002, 1(2):129-139.
18. Gur R.E., Maany V., Mozley P.D., Swanson C., Bilker W., Gur R.C. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998, 155(12):1711-1717.
19. Harms M.P., Wang L., Mamah D., Barch D.M., Thompson P.A., Csernansky J.G. Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. J. Neurosci. 2007, 27(50):13835-13842.
20. Hollingshead A.B. Four Factor Index of Social Status 1975, Yale University, New Haven, CT.
21. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Prevalence of alcohol use disorders in schizophrenia - a systematic review and meta-analysis. Acta Psychiatr Scand 2009, 120(2):85-96.
22. Mai J., Assheuer J., Paxinos G. Atlas of the Human Brain 1997, Academic Press, San Diego.
23. Makris N., Oscar-Berman M., Jaffin S.K., Hodge S.M., Kennedy D.N., Caviness V.S., et al. Decreased volume of the brain reward system in alcoholism. Biol Psychiatry 2008, 64(3):192-202.
24. Mamah D., Harms M.P., Wang L., Barch D., Thompson P., Kim J., et al. Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients. Biol Psychiatry 2008, 64(2):111-120.
25. Mamah D., Wang L., Barch D., de Erausquin G.A., Gado M., Csernansky J.G. Structural analysis of the basal ganglia in schizophrenia. Schizophr. Res. 2007, 89(1-3):59-71.
26. Manning V., Betteridge S., Wanigaratne S., Best D., Strang J., Gossop M. Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder. Schizophr. Res. 2009, 114(1-3):98-104.
27. Margolese H.C., Malchy L., Negrete J.C., Tempier R., Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr. Res. 2004, 67(2-3):157-166.
28. Mathalon D.H., Pfefferbaum A., Lim K.O., Rosenbloom M.J., Sullivan E.V. Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch Gen Psychiatry 2003, 60(3):245-252.
29. McClernon F.J. Neuroimaging of nicotine dependence: key findings and application to the study of smoking-mental illness comorbidity. J Dual Diagn 2009, 5(2):168-178.
30. Mechtcheriakov S., Brenneis C., Egger K., Koppelstaetter F., Schocke M., Marksteiner J. A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry 2007, 78(6):610-614.
31. Nixon K. Alcohol and adult neurogenesis: roles in neurodegeneration and recovery in chronic alcoholism. Hippocampus 2006, 16(3):287-295.
32. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004, 72(1):29-39.
33. Pfefferbaum A., Sullivan E.V., Rosenbloom M.J., Mathalon D.H., Lim K.O. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry 1998, 55(10):905-912.
34. Skinner H.A. Development and Validation of a Lifetime Alcohol Consumption Assessment Procedure 1982, Addiction Research Foundation, Toronto, Canada.
35. Smith M.J., Barch D.M., Csernansky J.G. Bridging the gap between schizophrenia and psychotic mood disorders: relating neurocognitive deficits to psychopathology. Schizophr. Res. 2009, 107(1):69-75.
36. Smith M.J., Barch D.M., Wolf T.J., Mamah D., Csernansky J.G. Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia. Schizophr. Res. 2008, 106(2-3):294-299.
37. Staal W.G., Hulshoff Pol H.E., Schnack H.G., Hoogendoorn M.L., Jellema K., Kahn R.S. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry 2000, 157(3):416-421.
38. Sullivan E.V., Deshmukh A., De Rosa E., Rosenbloom M.J., Pfefferbaum A. Striatal and forebrain nuclei volumes: contribution to motor function and working memory deficits in alcoholism. Biol Psychiatry 2005, 57(7):768-776.
39. Sullivan E.V., Pfefferbaum A. Neurocircuitry in alcoholism: a substrate of disruption and repair. Psychopharmacology (Berl) 2005, 180(4):583-594.
40. Sullivan E.V., Rosenbloom M.J., Lim K.O., Pfefferbaum A. Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structure. Neuropsychology 2000, 14(2):178-188.
41. Sullivan E.V., Rosenbloom M.J., Serventi K.L., Deshmukh A., Pfefferbaum A. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. Am J Psychiatry 2003, 160(6):1110-1116.
42. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am J Psychiatry 2010, 167(10):1178-1193.
43. Tsai G., Coyle J.T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 1998, 49:173-184.
44. Van Dongen C. Smoking and persistent mental illness: an exploratory study. J Psychosoc Nurs Ment Health Serv 1999, 37(11):26-34.
45. Varnas K., Okugawa G., Hammarberg A., Nesvag R., Rimol L.M., Franck J., et al. Cerebellar volumes in men with schizophrenia and alcohol dependence. Psychiatry Clin Neurosci 2007, 61(3):326-329.
46. Venkatesan R., Haacke E.M. Role of high resolution in magnetic resonance (MR) imaging: applications for MR angiography, intracranial T1-weighted imaging, and image interpolation. Int J Imag Syst Tech 1997, 8:529-543.
47. Wang L., Mamah D., Harms M.P., Karnik M., Price J.L., Gado M.H., et al. Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia. Biol Psychiatry 2008, 64(12):1060-1068.
48. Welch, K.A., McIntosh, A.M., Job, D.E., Whalley, H.C., Moorhead, T.W., Hall, J., et al. (in press). The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull.